as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
1.30%
Downside
7.42%
Upside
52 Week's Low
52 Week's High
29.33%
Downside
7.42%
Upside
Check Vanda Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$307.3M
EPS (TTM)
-2.3075
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.96%
PE Ratio (TTM)
-27.85
Industry PE ratio
-0.4116938110749186
PEG Ratio
-2.42
EBITDA
-113.1M
Revenue (TTM)
212.1M
Profit Margin
-39.70%
Return On Equity TTM
-16.72%
Track how Vanda Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.
Vanda Pharmaceuticals Inc. in the last 5 years
Lowest (-50.41x)
March 31, 2024
Today (-27.85x)
December 6, 2025
Industry (-0.41x)
December 6, 2025
Highest (87.99x)
September 30, 2022
Today’s Price to Earnings Ratio: -27.85x
Compare market cap, revenue, PE, and other key metrics of Vanda Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $307.3M | -59.63% | -27.85 | -39.70% | |
| BUY | $43.5B | 408.22% | -16.34 | -264.83% | |
| BUY | $61.5B | 253.6% | 1661.93 | 1.36% | |
| BUY | $117.3B | 99.49% | 32.16 | 31.35% | |
| BUY | $76.6B | 45.87% | 17.31 | 32.13% |
The Vanda Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vanda Pharmaceuticals Inc. investment value today
Current value as on today
₹1,17,532
Returns
₹17,532
(+17.53%)
Returns from Vanda Pharmaceuticals Inc. Stock
₹11,364 (+11.36%)
Dollar Returns*
₹6,168 (+6.17%)
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Vanda Pharmaceuticals Inc.. Average target price of $11.75
Get share price movements and forecasts by analysts on Vanda Pharmaceuticals Inc..
What analysts predicted
54.13%UPSIDE
Target Price
$11.75
Current Price
$5.39
Analyzed by
7 Analysts
Target
$11.75
Vanda Pharmaceuticals Inc. target price $11.75, a slight upside of 54.13% compared to current price of $5.39. According to 7 analysts rating.
Search interest for Vanda Pharmaceuticals Inc. Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:47% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 01 October
Thu, 02:34 AM
-Vanda Pharmaceuticals announces a collaborative framework with FDA to resolve disputes regarding HETLIOZ® and tradipitant.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, VNDA stock has moved up by 22.5%
Profit Spike
![]()
Netprofit is up for the last 3 quarters, -29.49M → -22.58M (in $), with an average increase of 14.4% per quarter
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 50.04M → 56.25M (in $), with an average increase of 5.7% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 977.7% return, outperforming this stock by 1028.0%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 159.2%
| Organisation | Vanda Pharmaceuticals Inc. |
| Headquarters | 2200 Pennsylvania Avenue NW, Washington, DC, United States, 20037 |
| Industry | Health Technology |
| CEO | Dr. Mihael H. Polymeropoulos M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Mihael H. Polymeropoulos M.D. | Founder, President, CEO & Chairman of The Board |
Mr. Kevin Patrick Moran | Senior VP, CFO & Treasurer |
Mr. Timothy Williams J.D. | Senior VP, General Counsel & Secretary |
Mr. Joakim Wijkstrom | Senior VP & Chief Marketing Officer |
Mr. Gunther Birznieks | Senior Vice President of Business Development |
Mr. Scott L. Howell | Chief People Officer |
Vanda Pharmaceuticals Inc. share price today is $5.39 as on at the close of the market. Vanda Pharmaceuticals Inc. share today touched a day high of $5.79 and a low of $5.32.
Vanda Pharmaceuticals Inc. share touched a 52 week high of $5.79 on and a 52 week low of $3.81 on . Vanda Pharmaceuticals Inc. stock price today i.e. is closed at $5.39,which is 6.91% down from its 52 week high and 41.50% up from its 52 week low.
Vanda Pharmaceuticals Inc. market capitalisation is $0.00T as on .
Indian investors can start investing in Vanda Pharmaceuticals Inc. (VNDA) shares with as little as ₹89.896 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.96 in Vanda Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vanda Pharmaceuticals Inc. share’s latest price of $5.39 as on December 6, 2025 at 2:29 am IST, you will get 1.8553 shares of Vanda Pharmaceuticals Inc.. Learn more about
fractional shares .
Vanda Pharmaceuticals Inc. stock has given -59.63% share price returns and 22.22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?